<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>AMA Publishing Group: Male Reproductive Medicine Topic Collection</title>
    <link>http://pubs.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 04 Jul 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:48:32 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@pubs.jamanetwork.com</managingEditor>
    <webMaster>webmaster@pubs.jamanetwork.com</webMaster>
    <item>
      <title>New Male Contraceptive?</title>
      <link>http://pubs.jamanetwork.com/article.aspx?articleID=1212289</link>
      <pubDate>Wed, 04 Jul 2012 00:00:00 GMT</pubDate>
      <author>Hampton T. </author>
      <description>&lt;span class="paragraphSection"&gt;The discovery of a key gene in sperm development may help researchers design a male contraceptive that (unlike conventional contraceptives) would not disrupt the production of hormones and would perhaps avoid such hormone-related adverse effects as irritability, mood swings, and acne (Smith LB et al. PLoS Genet. 2012;8[5]:e1002697). The finding could also provide new information on male infertility.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">308</prism:volume>
      <prism:number xmlns:prism="prism">1</prism:number>
      <prism:startingPage xmlns:prism="prism">21</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">21</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2012.6949</prism:doi>
      <guid>http://pubs.jamanetwork.com/article.aspx?articleID=1212289</guid>
    </item>
  </channel>
</rss>